首页> 美国卫生研究院文献>Risk Management and Healthcare Policy >Implications of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: A Proposed Observational Investigation by the Fail-to-Refill Project
【2h】

Implications of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: A Proposed Observational Investigation by the Fail-to-Refill Project

机译:Covid-19感染对意大利慢性疗法药物粘附的影响:拟议替代投资项目的观察调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Poor medication adherence leads to worsening of clinical outcomes and increases healthcare costs, especially in the context of chronic conditions. The effects of new COVID-19 infection and the measures taken in response to the outbreak are further increasing the concerns about medication adherence. Patients with chronic diseases, many of whom are older adults, have been strongly recommended to stay at home and avoid social contacts even with family members, who often provide support for regular use of therapies. Moreover, the mobilization of health personnel to the frontline of the COVID-19 infection could limit access to healthcare services. Within the Health-DB project, the Fail-To-Refill monitoring system was designed to evaluate the lack of adherence to chronic therapies in Italian clinical practice settings. Considering the date and dose coverage of last prescription, all patients due to refill this prescription for a chronic therapy in the last month were identified, and it was verified if they had the refill. The proposed future analysis, based on the data linkage between the current administrative flows of the Italian Local Health Units involved, will be carried out on a monthly basis from the beginning of the infection, and the “post-Covid-19” results will be compared with “pre-COVID-19” results, calculated for the last three years for patients with chronic therapies. Preliminary data herein presented showed a trend of increased failed refill during the months of lockdown for lipid-lowering and biologic therapies. The pre-COVID-19 trend compared to that of post-COVID-19 in the next months will be useful to estimate the percentage of failure to refill truly related to COVID-19 and on the measures adopted. The identification of patients that do not refill their prescriptions allows healthcare professionals to put in place actions aimed to promptly correct the lack of adherence, thus reducing the associated negative outcomes.
机译:贫困的药物依从性导致临床结果恶化,并提高了医疗保健成本,特别是在慢性条件的背景下。新Covid-19感染的影响和对爆发的回应采取的措施进一步提高了药物依从性的担忧。患有慢性疾病的患者,其中许多人都是老年人,强烈建议留在家里,即使与家庭成员也避免社会接触,他们经常提供对定期使用疗法的支持。此外,将卫生人员动员到Covid-19感染的前线可能会限制对医疗保健服务的访问。在Health-DB项目中,故障键入监控系统旨在评估意大利临床实践环境中对慢性疗法的缺乏依从性。考虑到最后一个处方的日期和剂量覆盖,确定所有患者由于在上个月内携带慢性疗法的慢性疗法,并且如果他们重新填充,则验证。基于所涉及的意大利地方健康单位的当前行政流程之间的数据联系,将在每月从感染开始,“COVID-19”结果的基础进行,拟议的未来分析将是与“预科卫生生19”结果相比,慢性疗法患者的过去三年计算。本文提出的初步数据显示出在脂质降低和生物疗法的锁定期间增加的糖填充的趋势。与Covid-19中的第19次趋势相比,未来几个月的趋势将有助于估计重新填充与Covid-19真正相关的失败的百分比以及通过的措施。鉴定不补充其处方的患者允许医疗保健专业人员制定旨在迅速纠正依赖的行动,从而减少相关的负面结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号